Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A22169 | 24769340 | Biochim Biophys Acta | Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease. | 2014 | Details |
A22170 | 24769275 | Clin Biochem | Low normal thyroid function attenuates serum alanine aminotransferase elevations in the context of metabolic syndrome and insulin resistance in white people. | 2014 | Details |
A22171 | 24768901 | J Hepatol | Perilipin-5 is regulated by statins and controls triglyceride contents in the hepatocyte. | 2014 | Details |
A22172 | 24768828 | J Hepatol | Weight trajectories through infancy and childhood and risk of non-alcoholic fatty liver disease in adolescence: the ALSPAC study. | 2014 | Details |
A22173 | 24768810 | Clin Gastroenterol Hepatol | Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. | 2014 | Details |
A22174 | 24768200 | Med Clin (Barc) | [Non-alcoholic fatty liver in children and adolescents with excess weight and obesity]. | 2014 | Details |
A22175 | 24766485 | Clin Sci (Lond) | Endoplasmic reticulum stress does not contribute to steatohepatitis in obese and insulin-resistant high-fat-diet-fed foz/foz mice. | 2014 | Details |
A22176 | 24766298 | Expert Opin Drug Discov | Evolving therapies for non-alcoholic steatohepatitis. | 2014 | Details |
A22178 | 24765691 | J Indian Med Assoc | Insulin resistance and hypothyroidism: a complex relationship in non-alcoholic fatty liver disease. | 2013 | Details |
A22179 | 24765505 | Clin Pract | Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease. | 2013 | Details |
A22180 | 24764677 | World J Gastroenterol | Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial. | 2014 | Details |
A22181 | 24764670 | World J Gastroenterol | Pediatric non-alcoholic steatohepatitis: the first report on the ultrastructure of hepatocyte mitochondria. | 2014 | Details |
A22182 | 24763885 | Eur Rev Med Pharmacol Sci | Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease. | 2014 | Details |
A22183 | 24763757 | PLoS One | Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease. | 2014 | Details |
A22184 | 24761121 | Pharmacognosy Res | Pioglitazone, quercetin and hydroxy citric acid effect on hepatic biomarkers in Non Alcoholic Steatohepatitis. | 2014 | Details |
A22185 | 24760992 | Am J Physiol Endocrinol Metab | Mice lacking NOX2 are hyperphagic and store fat preferentially in the liver. | 2014 | Details |
A22186 | 24759732 | PLoS One | Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials. | 2014 | Details |
A22187 | 24759667 | Gastroenterol Rep (Oxf) | Wedge and needle liver biopsies show discordant histopathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. | 2013 | Details |
A22188 | 24759663 | Gastroenterol Rep (Oxf) | Update of liver fibrosis and steatosis with transient elastography (Fibroscan). | 2013 | Details |
A22189 | 24758604 | BMC Gastroenterol | NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease. | 2014 | Details |
A22190 | 24758559 | Biochem J | Mitochondrial-nuclear genome interactions in non-alcoholic fatty liver disease in mice. | 2014 | Details |
A22191 | 24758097 | Invest Clin | [Hepatic steatosis, visceral fat and metabolic alterations in apparently healthy overweight/obese individuals]. | 2014 | Details |
A22192 | 24756192 | Neurol Sci | Non-alcoholic fatty liver disease in patients with migraine. | 2014 | Details |
A22193 | 24756010 | Ann Hepatol | Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease. | 2015 | Details |
A22194 | 24754380 | Pediatr Diabetes | Metabolic inflexibility and insulin resistance in obese adolescents with non-alcoholic fatty liver disease. | 2014 | Details |
A22195 | 24754177 | Zhongguo Zhong Yao Za Zhi | [Effect of pure total flavonoids from citrus on hepatic SIRT1/PGC-1alpha pathway in mice with NASH]. | 2014 | Details |
A22197 | 24753460 | Nephrol Dial Transplant | Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys. | 2014 | Details |
A22198 | 24753158 | Hepatology | Saturated free fatty acids induce cholangiocyte lipoapoptosis. | 2014 | Details |
A22199 | 24753132 | Hepatology | Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. | 2014 | Details |
A22200 | 24751397 | Aging (Albany NY) | Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease. | 2014 | Details |
A22201 | 24750688 | Liver Int | (Cleaved) CK18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allografts. | 2014 | Details |
A22202 | 24750664 | Liver Int | The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis. | 2014 | Details |
A22203 | 24750587 | Lipids Health Dis | L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease. | 2014 | Details |
A22204 | 24750217 | J Gastroenterol Hepatol | Serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis. | 2014 | Details |
A22205 | 24750171 | Clin Transplant | Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database. | 2014 | Details |
A22206 | 24749698 | Expert Opin Investig Drugs | Modulation of autophagy for the treatment of liver diseases. | 2014 | Details |
A22207 | 24748893 | Hepat Mon | Alanine aminotransferase elevation in obese infants and children: a marker of early onset non alcoholic Fatty liver disease. | 2014 | Details |
A22208 | 24748411 | PLoS One | Physiologically realistic and validated mathematical liver model reveals [corrected] hepatobiliary transfer rates for Gd-EOB-DTPA using human DCE-MRI data. | 2014 | Details |
A22209 | 24748332 | J Gastroenterol | Significance of exercise in nonalcoholic fatty liver disease in men: a community-based large cross-sectional study. | 2014 | Details |
A22210 | 24747563 | Biochem Biophys Res Commun | Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis. | 2014 | Details |
A22211 | 24746977 | Clin Nutr | Physical exercise antagonizes clinical and anatomical features characterizing Lieber-DeCarli diet-induced obesity and related metabolic disorders. | 2014 | Details |
A22213 | 24746708 | Gastroenterol Hepatol | [Non-invasive markers of fibrosis in the diagnosis of non-alcoholic fatty liver disease]. | 2014 | Details |
A22214 | 24745923 | Curr Pharm Des | Psoriasis and Vascular Risk : An Update. | 2014 | Details |
A22215 | 24745023 | Biomed Res Int | MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma. | 2014 | Details |
A22216 | 24743734 | Cell Death Dis | Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. | 2014 | Details |
A22217 | 24743702 | PLoS One | Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non-alcoholic fatty liver disease. | 2014 | Details |
A22218 | 24743504 | Eur J Gastroenterol Hepatol | Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies. | 2014 | Details |
A22219 | 24743428 | Arterioscler Thromb Vasc Biol | Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. | 2014 | Details |
A22220 | 24743120 | Georgian Med News | [Mechanisms of formation and progression of non-alcoholic fatty liver disease in type 2 diabetics]. | 2014 | Details |
A22222 | 24742471 | J Nutr Biochem | Insight into the impact of dietary saturated fat on tissue-specific cellular processes underlying obesity-related diseases. | 2014 | Details |
A22223 | 24741401 | Nutr Res Pract | Cordyceps militaris alleviates non-alcoholic fatty liver disease in ob/ob mice. | 2014 | Details |
A22224 | 24741297 | Clin Interv Aging | Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan. | 2014 | Details |
A22225 | 24740873 | Exp Biol Med (Maywood) | Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides. | 2014 | Details |
A22226 | 24740208 | Am J Clin Nutr | Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function in humans. | 2014 | Details |
A22227 | 24739055 | Clin Exp Pharmacol Physiol | Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice. | 2014 | Details |
A22228 | 24738701 | Aliment Pharmacol Ther | Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. | 2014 | Details |
A22229 | 24738611 | Clin Sci (Lond) | Ectopic lipid storage in non-alcoholic fatty liver disease is not mediated by impaired mitochondrial oxidative capacity in skeletal muscle. | 2014 | Details |
A22230 | 24738043 | Biomed Res Int | Nonalcoholic fatty liver disease and hepatocellular carcinoma. | 2014 | Details |
A22231 | 24737902 | Postgrad Med J | Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. | 2014 | Details |
A22232 | 24736032 | Clin Res Hepatol Gastroenterol | Ultrasonography-diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population. | 2014 | Details |
A22233 | 24735863 | J Ethnopharmacol | Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells. | 2014 | Details |
A22235 | 24733068 | Int J Mol Sci | Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. | 2014 | Details |
A22236 | 24732091 | PLoS One | Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance. | 2014 | Details |
A22237 | 24731940 | Int J Biochem Cell Biol | Regulation of microRNAs and their role in liver development, regeneration and disease. | 2014 | Details |
A22238 | 24731669 | Lancet Diabetes Endocrinol | Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. | 2014 | Details |
A22239 | 24731656 | Lancet Diabetes Endocrinol | Effects of iron overload on chronic metabolic diseases. | 2013 | Details |
A22240 | 24730643 | J Gastroenterol Hepatol | Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice. | 2014 | Details |
A22241 | 24729784 | Gastroenterol Res Pract | Chronic kidney disease and nonalcoholic Fatty liver disease-is there a link? | 2014 | Details |
A22243 | 24727595 | Mitochondrion | Physical exercise prevents and mitigates non-alcoholic steatohepatitis-induced liver mitochondrial structural and bioenergetics impairments. | 2014 | Details |
A22244 | 24726273 | Clin Res Hepatol Gastroenterol | Pediatric non-alcoholic fatty liver disease: recent advances. | 2014 | Details |
A22245 | 24721975 | Heart | Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. | 2014 | Details |
A22246 | 24721955 | Rev Gastroenterol Peru | [Knowledge on non alcoholic fatty liver disease in general practitioners from two districts of Chiclayo, Peru, during 2012]. | 2015 | Details |
A22247 | 24721245 | Zhonghua Gan Zang Bing Za Zhi | [Relationship between normal serum uric acid levels and nonalcoholic fatty liver disease in postmenopausal women]. | 2014 | Details |
A22248 | 24721241 | Zhonghua Gan Zang Bing Za Zhi | [A case-control study on the risk factors of hepatocellular carcinoma in Guizhou Province]. | 2014 | Details |
A22249 | 24719704 | Iran Red Crescent Med J | Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease. | 2014 | Details |
A22250 | 24719358 | FASEB J | Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis. | 2014 | Details |
A22251 | 24718860 | Dig Dis Sci | Nonalcoholic fatty liver disease increases risk for gastroesophageal reflux symptoms. | 2014 | Details |
A22252 | 24718630 | Arch Prev Riesgos Labor | [Prevalence of non-alcoholic fatty liver disease and associated risk factors among managers from the community of Madrid]. | 2014 | Details |
A22253 | 24717764 | Curr Opin Gastroenterol | State of the art: treatment of nonalcoholic steatohepatitis. | 2014 | Details |
A22254 | 24716593 | BMC Gastroenterol | Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease. | 2014 | Details |
A22255 | 24716226 | J Gastroenterol Hepatol | Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States. | 2014 | Details |
A22256 | 24716162 | J Tradit Complement Med | Recent advances in the herbal treatment of non-alcoholic Fatty liver disease. | 2013 | Details |
A22257 | 24715054 | Neurol Sci | The association between seizure predisposition and inflammation in a rat model of fatty liver disease. | 2014 | Details |
A22258 | 24714086 | Int J Mol Sci | Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma. | 2014 | Details |
A22259 | 24712752 | J Med Food | Antioxidant properties of proanthocyanidins attenuate carbon tetrachloride (CCl4)-induced steatosis and liver injury in rats via CYP2E1 regulation. | 2014 | Details |
A22260 | 24709815 | Nat Rev Gastroenterol Hepatol | NASH: the tribulations of conducting NASH trials. | 2014 | Details |
A22261 | 24709349 | Eur J Intern Med | Cholesterol control according to the presence of metabolic syndrome in coronary and diabetic patients. Relationship with non-alcoholic fatty liver disease. | 2014 | Details |
A22262 | 24708895 | Br J Nutr | Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice. | 2014 | Details |
A22263 | 24708244 | Endocrinology | GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency. | 2014 | Details |
A22264 | 24707151 | World J Gastroenterol | Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population. | 2014 | Details |
A22265 | 24706428 | J Pediatr Endocrinol Metab | Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents. | 2014 | Details |
A22266 | 24705404 | Diabetes | Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates. | 2014 | Details |
A22267 | 24704629 | Atherosclerosis | Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease. | 2014 | Details |
A22268 | 24704474 | Biochem Pharmacol | Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ. | 2014 | Details |
A22270 | 24702805 | Chin J Nat Med | Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice. | 2014 | Details |
A22271 | 24702768 | FEBS J | Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. | 2014 | Details |
A22272 | 24699882 | Endocrine | Identification and validation co-differentially expressed genes with NAFLD and insulin resistance. | 2014 | Details |
A22274 | 24698021 | Hepatol Res | Impact of non-alcoholic fatty liver disease on liver volume in humans. | 2014 | Details |
A22275 | 24697566 | Genet Test Mol Biomarkers | Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis. | 2014 | Details |
A22276 | 24696627 | Hepat Med | A lipid-rich gestational diet predisposes offspring to nonalcoholic fatty liver disease: a potential sequence of events. | 2014 | Details |